Please assess the completion status of the following clinical trial:

Trial Title: Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The subject is at least 50 years of age.~* The subjects' general health is adequate to comply with study procedures.~* The subject has been scheduled for a shunt placement procedure for the treatment of NPH.~Exclusion Criteria:~* The subject has a contraindication for MRI or PET.~* The subject is pregnant or lactating.~* The subject has a known or suspected hypersensitivity/allergy to \[18F\]flutemetamol or to any of the excipients.~* The subject has participated in any clinical study using an investigational agent within 30 days of dosing.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).